Management of patients with atrial fibrillation. A statement for healthcare professionals from the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association
Prystowsky, EN; Benson, DW, Jr; Fuster, V; Hart, RG; Kay, GN; Myerburg, RJ; Naccarelli, GV; Wyse, DG
HERO ID
156031
Reference Type
Journal Article
Year
1996
Language
English
PMID
| HERO ID | 156031 |
|---|---|
| In Press | No |
| Year | 1996 |
| Title | Management of patients with atrial fibrillation. A statement for healthcare professionals from the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association |
| Authors | Prystowsky, EN; Benson, DW, Jr; Fuster, V; Hart, RG; Kay, GN; Myerburg, RJ; Naccarelli, GV; Wyse, DG |
| Journal | Circulation |
| Volume | 93 |
| Issue | 6 |
| Page Numbers | 1262-1277 |
| Abstract | Atrial fibrillation (AF) is the most common sustained arrhythmia encountered in clinical practice. Its incidence increases with age and the presence of structural heart disease. It is a major cause of stroke, especially in the elderly. Although the causes are diverse, hypertension is common. Most patients experience palpitations, but fatigue, dyspnea, and dizziness are not uncommon. Patients with an uncontrolled ventricular response during AF may occasionally develop a tachycardia-induced cardiomyopathy. There are three therapeutic goals to consider for patients with AF: rate control, maintenance of sinus rhythm, and prevention of thromboembolism. The risks and benefits of each treatment must be considered for each patient. |
| Doi | 10.1161/01.CIR.93.6.1262 |
| Pmid | 8653857 |
| Wosid | WOS:A1996UA05300038 |
| Is Certified Translation | No |
| Dupe Override | No |
| Is Public | Yes |
| Language Text | English |
| Relationship(s) |
|